Pivotal bioVenture Partners Fund I, L.P., Ten Percent Owner at Entasis Therapeutics Holdings, holds 1.57M shares in Inozyme Pharma (Ticker: INZY), holds 1.79M shares in AKOUOS (Ticker: AKUS), holds 1.18M shares in Entasis Therapeutics Holdings (Ticker: ETTX). Most recently, Pivotal bioVenture Partners Fund I, L.P. Bought ― shares of Inozyme Pharma on Aug 03, 2023 for an estimated value of 4.00M.